All Walvax Biotechnology Co., Ltd. articles
-
NewsSafety, immunogenicity and preliminary efficacy of a randomized clinical trial of omicron XBB.1.5-containing bivalent mRNA vaccine
This study reported a very comprehensive evaluation of neutralization against 9 different SARS-CoV-2 variants by three types of variant vaccines of the same delivery system in a head-to-head design.
